Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ADBE vs GSK✓SelectedUSD · GSKADBE vs GSK performance historyLatest closeAs of-2.00%11/19
Stock and ETF performance explorer

ADBE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-63.8%
GSK return
+53.5%
Excess return
-117.4%
Maximum drawdown
-69.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.0%-1.6%-0.4%-1.8%
7D-7.1%-4.7%-2.3%-6.5%
30D-13.7%-4.7%-9.0%-13.2%
3M-18.6%-8.8%-9.9%-18.0%
6M-13.1%-4.6%-8.4%-12.6%
YTD-36.7%+1.0%-37.7%-37.0%
1Y-30.3%+6.9%-37.2%-31.1%
All-63.8%+53.5%-117.4%-64.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling